OUR MISSION

Our mission is that in 20 years Sweden will be leading the development of innovative treatments for disorders of the aging brain as a result of national and international partnerships between key players in academia, healthcare, industry, authorities and patient organizations.


ACTION PLAN

DEVELOP INNOVATION

  • Increased long-term funding for research on brain diseases from federal, state and private funders
  • Increased cooperation between Swedish researchers and interdisciplinary research groups
  • Neuropharmacology and neuroscience technology established as academic areas

CREATE SUSTAINABLE FUNDING

  • Increased long-term financing of all parts of the innovation process
  • Increased collaboration between researchers and industry
  • Increased openness to neurotechnological innovation in health care

ESTABLISH A NATIONAL NETWORK

  • Support the formation of a national innovation network for diseases of the aging brain
  • Support for annual network meetings, training initiatives and awareness campaigns
  • Support for the formation of a national innovation program for diseases of the aging brain

OPTIMIZE innovation process

  • Encourage entrepreneurship -“from idea to implementation”
  • Promote the development of biomarkers
  • Promote the development of clinical infrastructure and clinical trials
  • Evaluate health economic aspects

INCREASE COMPETENCE

  • Support for local training in entrepreneurship and drug discovery
  • Increase exchange between local educational initiatives
  • Increase mobility between industry, academia and healthcare
  • Raise the status of innovation activities in impact evaluation and appointment of academic services
  • Special support for healthcare professionals participating in clinical trials